Issue Area - Evidence-Based Medicine (EBM)
EBM Landscape Analysis
This reference guide identifies and documents all relevant organizations, activities, proposals, and key individuals associated with the evidence movement in the U.S., including anything of note under the rubric of evidence-based medicine (EBM), comparative effectivess, health (or medical) technology assessment (HTA), etc.
Full report (April 2008)
NICE: How does it work and what are the implications for the U.S.?
Executive Summary (April 2008)
Full report (April 2008)
This 4-part project examines the National Institute for Health and Clinical Excellence (NICE) and its operations, and the implications for comparative effectiveness reviews in the U.S.
- Part 1 entails a non-technical overview of NICE, encompassing its governance and organization, topic selection procedures, evidence requirements and assessment methods, and guidance dissemination and implementation.
- Part 2 provides an in-depth investigation of evidence requirements and assessment methods.
- Part 3 involves an analysis of public comments on NICE submitted to the House of Commons Health Select Committee, focusing on key stakeholder perspectives on the appraisal process and broader NICE operations.
- Part 4 examines NICE procedures and standards in the context of the U.S. landscape, and identifies those factors or forces unique to the U.S. marketplace, in comparison to the U.K. and other EU Member States, where applicable.
“Does The Work Of The National Institute For Health And Clinical Excellence (NICE) Have Any Relevance For The United States?” Corinna Sorenson, Michael Drummond, Panos Kanavos, and Alistair McGuire. ISPOR Connections, Vol. 14, No. 4, July/August 2008.
ISPOR Connections®, Copyright 2008. Reprinted by permission of the International Society for Pharmacoeconomics and Outcomes Research at www.ispor.org (ISPOR). All Rights Reserved.
|
